Experts Matter. Find Yours.
Connect for media, speaking, professional opportunities & more.
Filters
Ruogu Fang
Associate Professor | Associate DirectorUniversity of Florida
Ruogu Fang works on artificial intelligence-empowered precision brain health and brain/bio-inspired AI.
Jessica Winter
Professor of Biomedical, Chemical and Biomolecular Engineering | College of EngineeringThe Ohio State University
Biomedical expert, revolutionizing our knowledge of the relationship between nanoparticles and biology
Eric Simanek
Robert A. Welch Chair of ChemistryTexas Christian University
Dr. Simanek’s interests include whiskey, science education and basic scientific research aimed at the design of new medicines.
Nicole Onetto
Deputy Director and Chief Scientific OfficerOntario Institute for Cancer Research
Dr. Onetto is responsible for developing and maintaining relationships with cancer research stakeholders.
Helena Mistry
Director of Business DevelopmentImeka
Helena Mistry is a business development professional with experience in molecular biology, cancer research, and biochemistry.
Lyndsay V. Rhodes, Ph.D.
Expert in cellular, molecular and cancer biologyFlorida Gulf Coast University
Lyndsay Rhodes' research focuses on understanding breast cancer.
Thomas Schwaab, M.D., PH.D.
Bank of America Endowed Medical Director, Helen F. Graham Cancer Center & Research InstituteChristianaCare
Nationally recognized urologic surgeon and leader of strategic development
Paola Marignani PhD, MBA
ProfessorDalhousie University, Faculty of Medicine
Dr. Paola Marignani is a scientist dedicated to developing personalized precision medicine that will improve human health.
Sima Salahshor
Strategic Advisor | Life Sciences & HealthTech Program ManagementShiruy, Inc | University of Toronto, Faculty of Medicine
Health Innovation Advisory and Program Design & Management
Dr. Daniela Bota
Associate Dean of Clinical Research and Associate Professor of NeurologyUC Irvine
Dr. Daniela A. Bota is a UCI Health neuro-oncologist who specializes in the treatment of primary and metastatic brain tumors.